Proteomics as a Complementary Technique to Characterize Bladder Cancer.

Rubén López-Cortés1, Sergio Vázquez-Estévez2, Javier Álvarez Fernández2

  • 1Research Unit, Hospital Universitario Lucus Augusti (HULA), Servizo Galego de Saúde (SERGAS), 27002 Lugo, Spain.

Cancers
|November 13, 2021
PubMed
Summary

Bladder cancer (BC) research is advancing with molecular classifications and proteomics. This review highlights proteomics

Related Concept Videos